Hepatitis C News and Research

Latest Hepatitis C News and Research

New approach for delivering vaccines and for stimulating body's immune system to attack tumors

New approach for delivering vaccines and for stimulating body's immune system to attack tumors

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

Persons with severe symptoms of mental illness are at higher risk for being HIV-infected

Persons with severe symptoms of mental illness are at higher risk for being HIV-infected

Colour-changing ABC Syringe shortlisted for 2014 World Design Impact Prize

Colour-changing ABC Syringe shortlisted for 2014 World Design Impact Prize

Study findings suggest potential targets for treating HCV

Study findings suggest potential targets for treating HCV

Gilead submits NDA  to FDA for fixed-dose combination of ledipasvir and sofosbuvir for hepatitis C infection

Gilead submits NDA to FDA for fixed-dose combination of ledipasvir and sofosbuvir for hepatitis C infection

TSRI scientists discover unusual protein that probably helps some bacteria evade immune response

TSRI scientists discover unusual protein that probably helps some bacteria evade immune response

Researchers design new vaccine for human-infecting respiratory syncytial virus

Researchers design new vaccine for human-infecting respiratory syncytial virus

Alabama experts develop living document that includes new therapies for Hepatitis C virus

Alabama experts develop living document that includes new therapies for Hepatitis C virus

AbbVie's global sales reduce 1.8% to $5.111B in fourth quarter 2013

AbbVie's global sales reduce 1.8% to $5.111B in fourth quarter 2013

Daclatasvir–sofosbuvir combo effective in chronic HCV infection

Daclatasvir–sofosbuvir combo effective in chronic HCV infection

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Morbidity following liver transplant is highest among obese patients with diabetes

Morbidity following liver transplant is highest among obese patients with diabetes

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

Research roundup: Nursing home transitions; the impact of raising Medicare premiums; workers' views of job-based insurance

Research roundup: Nursing home transitions; the impact of raising Medicare premiums; workers' views of job-based insurance

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Study: Pro-inflammatory molecules linked with early death in HIV patients who abuse alcohol

Study: Pro-inflammatory molecules linked with early death in HIV patients who abuse alcohol

Severe infection associated with increased risk for psychotic illness

Severe infection associated with increased risk for psychotic illness

Monitoring individuals with chronic HBV is cost-effective strategy for China

Monitoring individuals with chronic HBV is cost-effective strategy for China

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.